Open original FDA record ↗Recall record
- FDA identifier
- Z-1880-2018
- Company in FDA record
- Visaris DOO
- FDA record creation date
- May 15, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A failure of the tube arm suspension is possible while the tube arm height is being adjusted. During tube height adjustment there is a small probability of failure of both the primary and redundant holding mechanisms, causing uncontrollable descent of the tube arm and a potential risk of injury to the patient.
Source facts
- Action
- Notification letters instruct users to perform the following actions: System end users should: Sign and return the Acknowledgement Form (part of this document). allow Visaris authorized service engineers access to perform the scheduled upgrade and refresher user training Read and familiarize themselves with the current user manual for Vision C devices and safety guidelines provided therein. Within the next four weeks Visaris will prepare and deliver an improved version of the elevation column mechanism for the Vision C devices to all relevant authorized distributors and service organizations. Visaris distributors will get in touch with you to initiate and agree a schedule of the field upgrade. Visaris engineers will at scheduled times upgrade the column mechanisms, including complete site acceptance and additional safety testing on all upgraded devices. During this activity users will be provided with the latest version of user manual and re-fresher system use training. This notice and relevant end user action information needs to be passed on to all system end user organizations. Please acknowledge receipt of this notification and maintain awareness of this notice and resulting actions for a period of three months to ensure effectiveness of the upgrade actions. For further questions, please call (239) 234-1735.
- Initiated
- 2018-04-05
- Root cause
- Other
- Terminated
- 2019-09-19
- Distribution
- Worldwide Distribution - US Distribution to the states of : FL, LA, MD, MS, NJ, and NY., and to the countries of : Czech Republic, Germany, Serbia, Switzerland, Taiwan, and United Kingdom.
- Recall number
- Z-1880-2018
- Recall status
- Terminated
- CDRH record ID
- 163733
- FDA record created
- 2018-05-15
- Recall event number
- 79848